User Name:

Password:

remember me

Forgot your password?

Not a member?

Join Now

News Topic - Merck

RSS feedDisplaying articles 1 - 10 of most recent articles

The Zacks Analyst Blog Highlights: Wells Fargo, UnitedHealth, Merck, Schwab and Raytheon The Zacks Analyst Blog Highlights: Wells Fargo, UnitedHealth, Merck, Schwab and Raytheon
Yahoo! News | Apr 23, 2019 2:35 PM [GMT] | comment? | recommend
Photo from Yahoo! News
Merck's Keytruda wins FDA approval as combination therapy for kidney cancer (Reuters) - The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer therapy, Keytruda, as part of a combination therapy for previously untreated patients with the most common type of kidney cancer, the company said on Monday. The dr
Yahoo! News | Apr 22, 2019 11:01 AM [GMT] | comment? | recommend
Merck's Keytruda wins FDA approval as combination therapy for kidney cancer The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer therapy, Keytruda, as part of a combination therapy for previously untreated patients with the most common type of kidney cancer, the company said on Monday.
Reuters | Apr 22, 2019 11:01 AM [GMT] | comment? | recommend
Photo from PR Newswire
Merck Manuals Survey: Medical Students Say Time Management is Greatest Barrier to Studying Success KENILWORTH, N.J., April 18, 2019 /PRNewswire/ -- In preparing for exams, today's medical students are turning to multi-tasking and multimedia content to manage overwhelming amounts of studying material, according to the findings of a survey released by th
PR Newswire | Apr 18, 2019 12:07 PM [GMT] | comment? | recommend
Health-care stocks keep getting hammered Wall Street says this is why Four of the Dow Jones Industrial Averages 10 biggest losers on Wednesday were health companies, including UnitedHealth Group Inc., Merck & Co. , Pfizer Inc.and Walgreens Boots Alliance Inc.
MarketWatch.com | Apr 18, 2019 11:20 AM [GMT] | comment? | recommend
German company wins battle to acquire Versum Materials Specialty materials company Versum Materials was all set to marry Entegris, which it called its equal. But then Merck KGaA, Darmstadt, Germany, swooped in, showing heavy interest in the Air Products spinoff. Versum rejected Merck KGaAs unsolicited offer,
Standard Speaker | Apr 16, 2019 04:00 AM [GMT] | comment? | recommend article from Hazleton, Pennsylvania
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA (pembrolizumab) and Virus-Specific T Cell Therapy Targ The collaboration will evaluate the safety and efficacy of Tessa's armored human papillomavirus-specific T cell (HPVST) therapy combined with Merck's KEYTRUDA (pembrolizumab) to address the limited number of effective treatment options for metastatic or r
PR Newswire | Apr 15, 2019 11:15 PM [GMT] | comment? | recommend
Merck's Keytruda Gets FDA Nod for Expanded Lung Cancer Group Merck (MRK) gets FDA approval to include overall survival data from the KEYNOTE-042 study on Keytruda's label.
Yahoo! News | Apr 12, 2019 3:08 PM [GMT] | comment? | recommend
Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal Glaxo (GSK) gets FDA approval for a new HIV medicine, Dovato. AstraZeneca (AZN)/Merck's (MRK) Lynparza gets approval in EU for metastatic breast cancer.
Yahoo! News | Apr 12, 2019 2:30 PM [GMT] | comment? | recommend
Merck KGaA clinches $6.5 billion Versum takeover in bet on electrochemicals Germany's Merck KGaA sealed a $6.5 billion takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris.
Reuters | Apr 12, 2019 2:05 PM [GMT] | comment? | recommend